Cargando…

HPV vaccination disparities and strategies to prevent oropharyngeal cancer in males

Detalles Bibliográficos
Autores principales:	Daniel, Casey L., Atkins, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383099/ https://www.ncbi.nlm.nih.gov/pubmed/34466373 http://dx.doi.org/10.1016/j.pmedr.2021.101521

Ejemplares similares

Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers
por: Schwartz, Beth I., et al.
Publicado: (2023)

Disparities in survival outcomes among Black patients with HPV‐associated oropharyngeal cancer
por: Baliga, Sujith, et al.
Publicado: (2023)

Disparate survival of late-stage male oropharyngeal cancer in Appalachia
por: Papenberg, Brenen W., et al.
Publicado: (2020)

Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis
por: Choi, Sung Eun, et al.
Publicado: (2021)

Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
por: Morand, Grégoire B., et al.
Publicado: (2022)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer
por: Gamez, Mauricio E., et al.
Publicado: (2021)

Can a single dose of the human papilloma virus (HPV) vaccine prevent oropharyngeal cancer?
por: Kanatas, A.
Publicado: (2020)

Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students
por: Farsi, Nada J, et al.
Publicado: (2020)

Sensitive HPV detection in oropharyngeal cancers
por: Winder, David M, et al.
Publicado: (2009)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

HPV Vaccination: An Underused Strategy for the Prevention of Cancer
por: Shapiro, Gilla K.
Publicado: (2022)

Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma
por: Yan, Emily Z., et al.
Publicado: (2023)

The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review
por: Macilwraith, Philip, et al.
Publicado: (2023)

Human Papilloma Virus (HPV) and the Current State of Oropharyngeal Cancer Prevention and Treatment
por: Gribb, Jacob P., et al.
Publicado: (2023)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer
por: Sung, Soo-Yoon, et al.
Publicado: (2022)

Advances in the Management of HPV-Related Oropharyngeal Cancer
por: De Felice, F., et al.
Publicado: (2019)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
por: Nielsen, Kristoffer Juul, et al.
Publicado: (2021)

Vaccination is the Most Effective Strategy for HPV Prevention
por: Savoy, Margot
Publicado: (2019)

Does HPV type affect outcome in oropharyngeal cancer?
por: Nichols, Anthony C, et al.
Publicado: (2013)

Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study
por: Eisenberg, Marisa C, et al.
Publicado: (2018)

Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer
por: Lim, Yvonne X., et al.
Publicado: (2023)

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy
por: Taku, Nicolette, et al.
Publicado: (2021)

HPV-mediated oropharyngeal carcinogenesis: An overview
por: Patil†, Shankargouda
Publicado: (2022)

HPV in oropharyngeal cancer: the basics to know in clinical practice
por: Elrefaey, S., et al.
Publicado: (2014)

Current perspectives on recurrent HPV-mediated oropharyngeal cancer
por: Guo, Theresa, et al.
Publicado: (2022)

Deep Learning Based HPV Status Prediction for Oropharyngeal Cancer Patients
por: Lang, Daniel M., et al.
Publicado: (2021)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
por: Haeggblom, Linnea, et al.
Publicado: (2017)

Editorial: HPV-Associated Cancers, Socio-Economic Disparity, and Vaccination
por: Alsbeih, Ghazi
Publicado: (2015)

Impact of Alcohol and Smoking on Outcomes of HPV-Related Oropharyngeal Cancer
por: Lai, Yu-Hsuan, et al.
Publicado: (2022)

B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model
por: Galán-Ortíz, Jorge R., et al.
Publicado: (2023)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
por: Lin, Chen, et al.
Publicado: (2022)

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
por: Chera, Bhishamjit S., et al.
Publicado: (2020)

Identification and chemoresistance of cancer stem cells in HPV-negative oropharyngeal cancer
por: Gunduz, Mehmet, et al.
Publicado: (2020)

A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide
por: Carlander, Amanda F., et al.
Publicado: (2021)

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis
por: Kentnowski, Marek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dnu1qrgn4to3esmt6e4pd167ed